AlphaCentric Advisors LLC Takes $374,000 Position in Surgery Partners, Inc. (NASDAQ:SGRY)

AlphaCentric Advisors LLC acquired a new position in Surgery Partners, Inc. (NASDAQ:SGRY) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm acquired 17,684 shares of the company’s stock, valued at approximately $374,000.

Several other large investors also recently added to or reduced their stakes in the business. Principal Financial Group Inc. bought a new position in Surgery Partners in the third quarter worth approximately $1,469,000. King Street Capital Management L.P. bought a new position in Surgery Partners in the 3rd quarter worth $46,748,000. Royce & Associates LP grew its holdings in Surgery Partners by 12.2% during the third quarter. Royce & Associates LP now owns 510,261 shares of the company’s stock valued at $16,451,000 after purchasing an additional 55,545 shares during the period. Geode Capital Management LLC increased its position in Surgery Partners by 2.4% in the third quarter. Geode Capital Management LLC now owns 1,864,346 shares of the company’s stock worth $60,117,000 after buying an additional 42,897 shares in the last quarter. Finally, Victory Capital Management Inc. lifted its position in shares of Surgery Partners by 140.4% during the 3rd quarter. Victory Capital Management Inc. now owns 1,330,399 shares of the company’s stock valued at $42,892,000 after buying an additional 777,038 shares in the last quarter.

Surgery Partners Stock Up 0.3 %

SGRY stock opened at $25.87 on Monday. The firm has a fifty day moving average price of $22.15 and a 200 day moving average price of $26.74. Surgery Partners, Inc. has a fifty-two week low of $19.50 and a fifty-two week high of $35.29. The company has a debt-to-equity ratio of 0.99, a current ratio of 1.80 and a quick ratio of 1.66.

Insider Buying and Selling at Surgery Partners

In other news, insider Harrison R. Bane sold 56,315 shares of the company’s stock in a transaction dated Friday, February 7th. The shares were sold at an average price of $25.64, for a total transaction of $1,443,916.60. Following the sale, the insider now directly owns 107,037 shares in the company, valued at approximately $2,744,428.68. This represents a 34.47 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO David T. Doherty sold 13,641 shares of Surgery Partners stock in a transaction dated Friday, February 7th. The stock was sold at an average price of $25.61, for a total value of $349,346.01. Following the completion of the transaction, the chief financial officer now owns 108,862 shares of the company’s stock, valued at approximately $2,787,955.82. This represents a 11.14 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 96,733 shares of company stock worth $2,480,106 over the last 90 days. 2.30% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

A number of equities analysts have weighed in on the stock. Royal Bank of Canada dropped their price target on shares of Surgery Partners from $49.00 to $35.00 and set an “outperform” rating for the company in a research report on Wednesday, November 20th. Macquarie reissued an “outperform” rating and set a $34.00 price target on shares of Surgery Partners in a report on Tuesday, November 19th. Bank of America began coverage on Surgery Partners in a research note on Monday, December 16th. They issued a “buy” rating and a $30.00 price objective for the company. Finally, JPMorgan Chase & Co. decreased their target price on Surgery Partners from $38.00 to $28.00 and set a “neutral” rating on the stock in a research note on Tuesday, December 3rd. One analyst has rated the stock with a sell rating, three have given a hold rating and seven have given a buy rating to the company’s stock. According to data from MarketBeat.com, Surgery Partners currently has an average rating of “Moderate Buy” and an average price target of $36.56.

Surgery Partners Company Profile

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.